Radiation-associated breast angiosarcomas are associated with poor clinical outcomes including high recurrence rates and poor survival.
RT-AS has high local/distant recurrence rates, limited duration on standard chemotherapy and poor disease-specific survival.
D’Angelo et al. (Tue,) studied this question.